Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06160700 · ClinicalTrials.gov registry record
Serial Testing To Assess Cognitive Function In Cancer
A clinical trial, sponsored by Indiana University.
- Terminated
- Registry status
- 54
- Enrollment target
NCT06160700 is a clinical trial that was terminated before completion, run by Indiana University. The registered enrollment target is 54 participants.
The verdict
NCT06160700 was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of immunotherapy on cognitive function of cancer patients and follow them clinically over a period of six months with the Montreal cognitive assessment (MoCA) to assess changes in cognition.
Interventions
- BEHAVIORAL Montreal Cognitive Assessment (MoCA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2022-04-20 |
| Est. Completion | 2024-03-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06160700
The ClinicalTrials.gov registry entry for NCT06160700 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Montreal Cognitive Assessment (MoCA) is the first listed.
NCT06160700 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06160700 about?
NCT06160700 is a clinical study titled "Serial Testing To Assess Cognitive Function In Cancer". The purpose of this study is to examine the effects of immunotherapy on cognitive function of cancer patients and follow them clinically over a period of six months with the Montreal cognitive assessment (MoCA) to assess changes in cognition.
What is the current status of trial NCT06160700?
This trial is currently terminated. The enrollment target is 54 participants. The study started on 2022-04-20. Estimated completion is 2024-03-12.
What interventions are being tested in trial NCT06160700?
The interventions under investigation include: Montreal Cognitive Assessment (MoCA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06160700?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.